Can HER2 overexpression predict response to pegylated liposomal doxorubicin in metastatic breast cancer patients?

被引：2
|
作者：
Fabi, A [1 ]
Ferretti, G [1 ]
Salesi, N [1 ]
Papaldo, P [1 ]
Carlini, P [1 ]
Ciccarese, M [1 ]
Di Cocco, B [1 ]
Cecere, F [1 ]
Nardoni, C [1 ]
Felici, A [1 ]
Cognetti, F [1 ]
机构：
[1] Regina Elena Inst Canc Res, Div Med Oncol A, I-00144 Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷 / 03期
关键词：
D O I：
10.1093/annonc/mdi078
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：516 / 517
页数：2
相关论文
共 50 条
  • [1] Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer
    Minisini, Alessandro M.
    Andreetta, Claudia
    Fasola, Gianpiero
    Puglisi, Fabio
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 331 - 342
  • [2] Trastuzumab Combined with Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer
    Christodoulou, Christos
    Kostopoulos, Ioannis
    Kalofonos, Haralabos P.
    Lianos, Evangelos
    Bobos, Mattheos
    Briasoulis, Evangelos
    Gogas, Helen
    Razis, Evangelia
    Skarlos, Dimosthenis V.
    Fountzilas, George
    ONCOLOGY, 2009, 76 (04) : 275 - 285
  • [3] HER2 overexpression in metastatic breast cancer: development of therapies
    Pivot, X.
    Jary, M.
    Dobi, E.
    Bazan, F.
    Chaigneau, L.
    Cals, L.
    Almotlak, H.
    Montcuquet, P.
    Meneveau, N.
    Villanueva, C.
    ONCOLOGIE, 2012, 14 (01) : 37 - 40
  • [4] HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer
    Moliterni, A
    Ménard, S
    Valagussa, P
    Biganzoli, E
    Boracchi, P
    Balsari, A
    Casalini, P
    Tomasic, G
    Marubini, E
    Pilotti, S
    Bonadonna, G
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (03) : 458 - 462
  • [5] A phase I study of MM-302, a HER2-targeted PEGylated liposomal doxorubicin, in patients with HER2+metastatic breast cancer
    LoRusso, Patricia
    Krop, Ian
    Miller, Kathy
    Ma, Cynthia
    Siegel, Barry A.
    Shields, Anthony F.
    Molnar, Istvan
    Wickham, Thomas
    Reynolds, Joseph
    Campbell, Karen
    Hendriks, Bart
    McClure, Ty
    Moyo, Victor
    Munster, Pamela
    CANCER RESEARCH, 2015, 75
  • [6] Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: A multicenter phase II trial
    Chia, Stephen
    Clemons, Mark
    Martin, Lee-Ann
    Rodgers, Angela
    Gelmon, Karen
    Pond, Gregory R.
    Panasci, Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2773 - 2778
  • [7] Comment on Pegylated Liposomal Doxorubicin Plus Docetaxel in Metastatic Breast Cancer
    Smith, Thomas J.
    Hillner, Bruce E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (08) : E128 - E128
  • [8] A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
    Huober, Jens
    Fett, Werner
    Nusch, Arnd
    Neise, Michael
    Schmidt, Marcus
    Wischnik, Arthur
    Gerhardt, Steffen
    Goehler, Thomas
    Lueck, Hans-Joachim
    Rost, Andreas
    BMC CANCER, 2010, 10
  • [9] A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
    Jens Huober
    Werner Fett
    Arnd Nusch
    Michael Neise
    Marcus Schmidt
    Arthur Wischnik
    Steffen Gerhardt
    Thomas Goehler
    Hans-Joachim Lück
    Andreas Rost
    BMC Cancer, 10
  • [10] Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study
    Collea, R. P.
    Kruter, F. W.
    Cantrell, J. E.
    George, T. K.
    Kruger, S.
    Favret, A. M.
    Lindquist, D. L.
    Melnyk, A. M.
    Pluenneke, R. E.
    Shao, S. H.
    Crockett, M. W.
    Asmar, L.
    O'Shaughnessy, J.
    ANNALS OF ONCOLOGY, 2012, 23 (10) : 2599 - 2605
12345